Literature DB >> 22242681

Radiofrequency ablation does not induce apoptosis in the rat myocardium.

Luis F Dos Santos1, Ednei Antonio, Andrey Serra, Gabriela Venturini, Mieko Okada, Sergio Araújo, Paulo Tucci, Angelo De Paola, Guilherme Fenelon.   

Abstract

BACKGROUND: The mechanisms implicated in the genesis of delayed radiofrequency (RF) effects remain unclear, but may be related to extension of the lesion beyond the region of coagulative necrosis. The role of apoptosis in this process has not been previously reported. We assessed whether RF promotes apoptosis in the region surrounding acute ablation lesions in a rat model.
METHODS: Wistar rats (n=30; weight 300 g) were anesthesized, the chest was opened, and the heart was exposed. A modified unipolar RF ablation (custom catheter 4.5-mm-tip diameter, 12 Watts, 10 seconds) was undertaken on the left ventricular anterolateral epicardial surface and the chest was closed. After 2 hours, animals were killed for histological (hematoxylin and eosin, TdT-mediated dUTP Nick End-Labeling [TUNEL] assay) and immunohistochemical (anti-BAD and anti-caspase 3 antibodies) analysis (n=18). Additional animals (n=12) were sacrificed at 2 (n=3), 24 (n=3), 48 (n=3), and 72 hours (n=3) after ablation exclusively for anti-BAD Western Blotting analysis.
RESULTS: Lesions were characterized by well-defined regions of coagulative necrosis. In 18/18 (100%) animals, TUNEL assay revealed positive luminescent reaction cells in the region surrounding the lesion, extending up to 2 mm from the border zone. However, microscopic evaluation of the nuclei and immunohistochemical and anti-BAD Western Blotting analysis were negative in all (100%) rats. Thus, positive TUNEL reaction in the periphery of the ablation lesion likely reflects nonspecific DNA damage.
CONCLUSION: RF ablation does not promote apoptosis in the periphery of the myocardial lesion. This finding may have implications for the elucidation of late lesion extension following RF ablation. ©2012, The Authors. Journal compilation ©2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22242681     DOI: 10.1111/j.1540-8159.2011.03306.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  Rabbit model to simulate the residual conduction gaps after radiofrequency ablation on the anterior wall of left atrial appendage.

Authors:  Huaner Ni; Ying Zhuge; Lin Li; Weifeng Li; Congcong Zhao; Yujie Wang; Fang Wang
Journal:  J Interv Card Electrophysiol       Date:  2018-04-10       Impact factor: 1.900

2.  Combination of doxorubicin liposomes with left atrial appendage radiofrequency catheter ablation to reduce post-ablation recovery of electrical conduction.

Authors:  Ying Zhuge; Huan-Er Ni; Yu-Jie Wang; Mu-Ye He; Jun-Shan Wang; Feng Gao; Fang Wang
Journal:  Int J Nanomedicine       Date:  2018-12-27

3.  Preparation of liposomal amiodarone and investigation of its cardiomyocyte-targeting ability in cardiac radiofrequency ablation rat model.

Authors:  Ying Zhuge; Zhi-Feng Zheng; Mu-Qing Xie; Lin Li; Fang Wang; Feng Gao
Journal:  Int J Nanomedicine       Date:  2016-05-27

4.  Atrial fibrillation promotion in a rat model of heart failure induced by left ventricle radiofrequency ablation.

Authors:  Luis Dos Santos; Ednei L Antonio; Andrey J Serra; Amanda Yoshizaki; Larissa Seibt; Flavio A Silva; Gisele K Couto; Luciana V Rossoni; Paulo Tucci; Angelo A de Paola; Guilherme Fenelon
Journal:  Int J Cardiol Heart Vasc       Date:  2018-09-22

5.  Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation for atrial fibrillation.

Authors:  Yosuke Nakatani; Soumaya Sridi-Cheniti; Ghassen Cheniti; F Daniel Ramirez; Cyril Goujeau; Clementine André; Takashi Nakashima; Charles Eggert; Christopher Schneider; Raju Viswanathan; Philipp Krisai; Takamitsu Takagi; Tsukasa Kamakura; Konstantinos Vlachos; Nicolas Derval; Josselin Duchateau; Thomas Pambrun; Remi Chauvel; Vivek Y Reddy; Michel Montaudon; François Laurent; Frederic Sacher; Mélèze Hocini; Michel Haïssaguerre; Pierre Jaïs; Hubert Cochet
Journal:  Europace       Date:  2021-11-08       Impact factor: 5.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.